Beyond the altered clock gene expression, intact rhythms in the glioblastoma multiforme cell line T98G during proliferation result in a timed window of vulnerability for the chemotherapeutical agent bortezomib.53 The gene discussed is CLOCK; the disease is glioblastoma.